Biomimetic nanomedicines for precise atherosclerosis theranostics
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...
Saved in:
Main Authors: | Ying Tao (Author), Xinmiao Lan (Author), Yang Zhang (Author), Chenxing Fu (Author), Lu Liu (Author), Feng Cao (Author), Weisheng Guo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Theranostic Nanomedicine in Oncology
Published: (2020) -
Theranostic nanomedicine: Potential therapeutic epitome
by: Upendra Nagaich
Published: (2015) -
Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy
by: Xiaoqiu Xu, et al.
Published: (2022) -
Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
by: Alejandro Baeza, et al.
Published: (2020) -
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
by: Lingling Zhu, et al.
Published: (2023)